Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy
CHICAGO, IL / ACCESS Newswire / December 24, 2025 / Healthcare investors have seen this movie before. A company leans...
Day: December 24, 2025
Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules
$4.1 million upfront with up to approximately $8.3 million of potential additional gross proceeds upon the exercise in full of...
S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody’s Ratings Agency Revises Outlook to Positive
The two updates underscore Teva’s strong execution of its Pivot to Growth strategy and commitment to financial discipline.Moody's affirmed Teva's...
PharmAla Issues Audited Year End 2025 and Unaudited Q1 Fiscal 2026 Financial Statements
TORONTO, Dec. 24, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a...
MAIA Biotechnology Board Members Continue to Participate in Private Placement Financings
Purchases reflect strong confidence in the scientific differentiation and commercial potential of ateganosine CHICAGO, Dec. 24, 2025 (GLOBE NEWSWIRE) --...
Human Appeal launches e-greeting card collection to support emergency charity projects
New feature enables charity to respond faster to emergenciesMANCHESTER, United Kingdom, Dec. 24, 2025 (GLOBE NEWSWIRE) -- Leading UK humanitarian...
DXS International plc (AQSE: DXSP) Update on Cyber Security Incident
24 December 2025 DXS INTERNATIONAL PLC (AQSE: DXSP) Update on Cyber Security Incident The Board of DXS International plc (“the...
Press Release: Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline
Sanofi to acquire Dynavax, adding a marketed adult hepatitis B vaccine and phase 1/2 shingles candidate to the pipeline Paris,...
Press Release: Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis
Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Paris, December 24, 2025. The US Food...
Best Peptides for Muscle Growth: Prescription Sermorelin Access, Injectable vs. Dissolving Tablets, and Realistic Expectations
Platform Analysis: Injectable vs. Dissolving Tablet Formats, Prescription Requirements, Monthly Subscription Costs, and Timeline Expectations for Growth Hormone Secretagogue TherapyAUSTIN,...
U.S. FDA Approves Agios’ AQVESME™ (mitapivat) for the Treatment of Anemia in Adults with Alpha- or Beta-Thalassemia
AQVESME is the only FDA-approved medicine for anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemiaMarketed under AQVESME brand name...
Best BPC-157 Oral Supplements: ProHealth’s Triple-Tested Formula Examined as Peptide Quality Verification Becomes Consumer Priority Heading Into 2026
36-Year Company's Oral Capsule Format vs. Injectable BPC-157: Third-Party Lab Testing, Bioavailability Questions, and Regulatory Status ExaminedCARPINTERIA, Dec. 23, 2025...
Pelthos Therapeutics Expands Board of Directors with the Appointment of Andrew Einhorn
Seasoned executive brings four decades of finance, capital markets, and life sciences experienceDURHAM, N.C., Dec. 23, 2025 (GLOBE NEWSWIRE) --...
Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change
RAMAT GAN, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company...
SeaStar Medical Announces 1-for-10 Reverse Split
DENVER, Dec. 23, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming...
Organogenesis Announces Initiation of Biologics License Application for ReNu®
Initial modules submitted to FDA under rolling review; final modules expected in the first half of 2026CANTON, Mass., Dec. 23,...
Algernon Announces Increase to Private Placement Financing to $750,000 and Close of Third Tranche
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Dec. 23, 2025 (GLOBE...
Vor Bio Appoints RA Capital’s Andrew Levin, M.D., Ph.D., and Forbion’s Wouter Joustra to Board of Directors
BOSTON, Mass., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Vor Biopharma Inc. (Nasdaq: VOR), a clinical-stage biotechnology company dedicated to transforming...
Singlera Genomics Signs European Distribution and Research Agreement with Pure Medical for Cancer Detection Products
LA JOLLA, Calif., Dec. 23, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics, a company focused on the development and application of...
Sequana Medical announces execution of letter of intent to amend terms of the Kreos Loan
Ghent, Belgium, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Sequana Medical announces execution of letter of intent to amend terms of...